https://news.medxy.ai/zh/83520-2/Medxy AIzh2026-10-12T03:18:17-07:00丝蛋白-透明质酸喉成形术：评估其治疗声门闭合不全的安全性和有效性 https://news.medxy.ai/ja/silk-protein-hyaluronic-laryngoplasty/Medxy AIja2026-10-12T03:17:59-07:00シルク蛋白-ヒアルロン酸喉頭形成術：声門不全に対する安全性と有効性の検証 https://news.medxy.ai/vi/silk-hyaluronic-acid/Medxy AIvi2026-10-12T03:17:41-07:00Tạo Hình Thanh Quản Silk-Hyaluronic Acid: Đánh Giá Tính An Toàn Và Hiệu Quả Trong Điều Trị Hở Thanh Môn https://news.medxy.ai/silk-hyaluronic-acid-laryngoplasty-evaluating-safety-and-efficacy-in-treating-glottic-insufficiency/Medxy AIen2026-10-12T03:17:19-07:00Silk-Hyaluronic Acid Laryngoplasty: Evaluating Safety and Efficacy in Treating Glottic Insufficiency https://news.medxy.ai/zh/appendicitis-antibiotics/Medxy AIzh2026-10-12T03:16:43-07:00急性阑尾炎阑尾切除术后抗生素是否仍需常规使用？一项大型回顾性研究的再审视 https://news.medxy.ai/ja/appendectomy-antibiotics-need/Medxy AIja2026-10-12T03:16:20-07:00急性虫垂炎の虫垂切除術後に抗菌薬は本当に必要か：大規模後ろ向き研究からの示唆 https://news.medxy.ai/vi/antibiotics-after-appendectomy/Medxy AIvi2026-10-12T03:15:57-07:00Kháng sinh sau cắt ruột thừa ở viêm ruột thừa cấp: Có cần dùng thường quy không? Bằng chứng từ một nghiên cứu hồi cứu quy mô lớn https://news.medxy.ai/reevaluating-postoperative-antibiotic-use-after-appendectomy-in-acute-appendicitis-insights-from-a-large-retrospective-study/Medxy AIen2026-10-12T03:15:35-07:00Reevaluating Postoperative Antibiotic Use After Appendectomy in Acute Appendicitis: Insights from a Large Retrospective Study https://news.medxy.ai/ja/ivf-multiple-pregnancy-reduction/Medxy AIja2026-10-12T03:14:56-07:00IVF後の多胎妊娠を減らすには：RCOG Scientific Impact Paper No.22 第3版（2026）に基づく実践ガイド https://news.medxy.ai/vi/83501-2/Medxy AIvi2026-10-12T03:14:23-07:00Giảm thiểu tình trạng đa thai sau thụ tinh trong ống nghiệm (IVF): Tài liệu về Tác động Khoa học số 22 của RCOG (Ấn bản lần thứ 3, 2026) – Hướng dẫn thực hành https://news.medxy.ai/zh/reduce-ivf-multiple-pregnancy/Medxy AIzh2026-10-12T03:13:52-07:00降低IVF后的多胎妊娠：RCOG第22号Scientific Impact Paper（第3版，2026）实用指南 https://news.medxy.ai/reducing-multiple-pregnancies-after-ivf-practical-guidance-from-rcog-scientific-impact-paper-no-22-3rd-ed-2026/Medxy AIen2026-10-12T03:13:23-07:00Reducing Multiple Pregnancies After IVF: Practical Guidance from RCOG Scientific Impact Paper No.22 (3rd Ed., 2026) https://news.medxy.ai/zh/child-varices-outcome/Medxy AIzh2026-10-12T03:12:15-07:00儿童首次静脉曲张出血后的结局与死亡率：来自全球多中心研究的启示 https://news.medxy.ai/ja/pediatric-variceal-bleeding/Medxy AIja2026-10-12T03:11:54-07:00小児初回静脈瘤出血後の転帰と死亡率：国際多施設研究から得られた知見 https://news.medxy.ai/vi/83489-2/Medxy AIvi2026-10-12T03:11:31-07:00Kết cục và tỷ lệ tử vong sau đợt xuất huyết do giãn tĩnh mạch lần đầu ở trẻ em https://news.medxy.ai/outcomes-and-mortality-after-pediatric-first-variceal-hemorrhage-insights-from-a-global-multicenter-study/Medxy AIen2026-10-12T03:11:08-07:00Outcomes and Mortality After Pediatric First Variceal Hemorrhage: Insights from a Global Multicenter Study https://news.medxy.ai/ja/parkinsons-physical-activity/Medxy AIja2026-10-12T03:10:24-07:00パーキンソン病の運動・認知機能進行に対する身体活動の影響：縦断コホート研究 https://news.medxy.ai/vi/physical-activity-parkinsons/Medxy AIvi2026-10-12T03:10:04-07:00Hoạt động thể chất liên quan thế nào đến tiến triển vận động và nhận thức ở bệnh Parkinson? Kết quả từ một nghiên cứu đoàn hệ theo dõi dọc https://news.medxy.ai/physical-activity-and-motor-and-cognitive-progression-in-parkinson-disease-a-longitudinal-cohort-study/Medxy AIen2026-10-12T03:09:46-07:00Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study https://news.medxy.ai/zh/polygenic-risk-lifestyle-diabetes/Medxy AIzh2026-10-12T03:09:11-07:00整合多基因风险评分与生活方式因素：预测日本人群2型糖尿病发生的新思路 https://news.medxy.ai/ja/type-2-diabetes-risk-japan/Medxy AIja2026-10-12T03:08:52-07:00日本人における2型糖尿病発症予測：多遺伝子リスクスコアと生活習慣因子の統合 https://news.medxy.ai/vi/type-2-diabetes-risk/Medxy AIvi2026-10-12T03:08:30-07:00Kết hợp điểm nguy cơ đa gen và yếu tố lối sống để dự đoán khởi phát đái tháo đường type 2 ở người Nhật https://news.medxy.ai/integrating-polygenic-risk-scores-and-lifestyle-factors-to-predict-type-2-diabetes-onset-in-the-japanese-population/Medxy AIen2026-10-12T03:08:07-07:00Integrating Polygenic Risk Scores and Lifestyle Factors to Predict Type 2 Diabetes Onset in the Japanese Population https://news.medxy.ai/zh/otc-painkillers-concussion/Medxy AIzh2026-10-12T03:07:30-07:00非处方镇痛药对脑震荡恢复的影响：CARE 联合体研究带来的启示 https://news.medxy.ai/ja/over-the-counter-painkillers/Medxy AIja2026-10-12T03:07:13-07:00脳震盪回復における市販鎮痛薬の影響：CARE Consortium研究から得られた知見 https://news.medxy.ai/vi/otc-painkillers-recovery/Medxy AIvi2026-10-12T03:06:43-07:00Tác động của thuốc giảm đau không kê đơn lên quá trình hồi phục sau chấn động não: những phát hiện từ nghiên cứu CARE Consortium https://news.medxy.ai/impact-of-otc-analgesics-on-concussion-recovery-insights-from-the-care-consortium-study/Medxy AIen2026-10-12T03:06:22-07:00Impact of OTC Analgesics on Concussion Recovery: Insights from the CARE Consortium Study https://news.medxy.ai/zh/ethiopia-stroke-falls/Medxy AIzh2026-10-12T03:05:46-07:00埃塞俄比亚卒中幸存者跌倒相关损伤负担沉重：阿姆哈拉州多中心研究揭示关键风险因素 https://news.medxy.ai/ja/stroke-fall-injuries-ethiopia/Medxy AIja2026-10-12T03:05:28-07:00エチオピアの脳卒中サバイバーにおける転倒関連損傷の高負担：アムハラ州多施設研究からの示唆 https://news.medxy.ai/vi/stroke-fall-burden/Medxy AIvi2026-10-12T03:05:08-07:00Gánh nặng chấn thương do té ngã ở người sống sót sau đột quỵ tại Ethiopia: Kết quả từ một nghiên cứu đa trung tâm ở vùng Amhara https://news.medxy.ai/high-burden-of-fall-related-injuries-among-stroke-survivors-in-ethiopia-insights-from-a-multicenter-study-in-amhara-region/Medxy AIen2026-10-12T03:04:46-07:00High Burden of Fall-Related Injuries Among Stroke Survivors in Ethiopia: Insights from a Multicenter Study in Amhara Region https://news.medxy.ai/zh/tongue-development-immunity/Medxy AIzh2026-10-12T03:04:07-07:00舌部发育不良的免疫谱：识别高风险患者的生物标志物 https://news.medxy.ai/ja/immune-profiling-tongue/Medxy AIja2026-10-12T03:03:47-07:00舌可動部異形成における免疫プロファイリング：高リスク患者を層別化するバイオマーカーの同定 https://news.medxy.ai/vi/immune-profile-tongue-dysplasia/Medxy AIvi2026-10-12T03:03:24-07:00Hồ sơ miễn dịch trong loạn sản lưỡi mặt bụng: Tìm kiếm các dấu ấn sinh học để phân tầng bệnh nhân nguy cơ cao https://news.medxy.ai/immune-profiling-in-oral-tongue-dysplasia-identifying-biomarkers-to-stratify-high-risk-patients/Medxy AIen2026-10-12T03:03:07-07:00Immune Profiling in Oral Tongue Dysplasia: Identifying Biomarkers to Stratify High-Risk Patients https://news.medxy.ai/zh/vision-restoration-progress/Medxy AIzh2026-10-12T03:02:25-07:00视功能修复新进展：光遗传学治疗为视网膜色素变性患者带来希望 https://news.medxy.ai/ja/83440-2/Medxy AIja2026-10-12T03:02:07-07:00視機能回復の新たな進展：光遺伝学治療が網膜色素変性症の患者に希望をもたらす https://news.medxy.ai/vi/gene-therapy-retinitis-pigmentosa/Medxy AIvi2026-10-12T03:01:47-07:00Mở ra hy vọng mới cho bệnh nhân viêm sắc tố võng mạc: liệu pháp quang di truyền cho thấy triển vọng phục hồi thị lực https://news.medxy.ai/advancing-vision-optogenetic-therapy-offers-hope-for-retinitis-pigmentosa-patients/Medxy AIen2026-10-12T03:01:29-07:00Advancing Vision: Optogenetic Therapy Offers Hope for Retinitis Pigmentosa Patients https://news.medxy.ai/zh/venetoclax-cll-prognosis/Medxy AIzh2026-10-11T03:53:31-07:00Venetoclax一线治疗背景下慢性淋巴细胞白血病端粒长度的预后意义 https://news.medxy.ai/ja/83256-2/Medxy AIja2026-10-11T03:53:13-07:00ベネトクラクスによる一次治療下における慢性リンパ球性白血病のテロメア長が持つ予後学的意義 https://news.medxy.ai/vi/83255-2/Medxy AIvi2026-10-11T03:52:51-07:00Ý nghĩa tiên lượng của chiều dài telomere trong bệnh bạch cầu lympho mạn tính được điều trị bằng venetoclax ở bước một https://news.medxy.ai/prognostic-significance-of-telomere-length-in-chronic-lymphocytic-leukemia-under-venetoclax-based-first-line-therapy/Medxy AIen2026-10-11T03:52:30-07:00Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy https://news.medxy.ai/zh/83252-2/Medxy AIzh2026-10-11T03:51:41-07:00Glofitamab 联合 Polatuzumab-R-CHP 治疗初诊弥漫大 B 细胞淋巴瘤展现出卓越疗效与安全性：一项多中心 II 期研究 https://news.medxy.ai/ja/83251-2/Medxy AIja2026-10-11T03:51:25-07:00新規診断されたびまん性大細胞型B細胞リンパ腫におけるグロフィタマブとポラツズマブ-R-CHPの併用療法の優れた有効性と安全性：多施設共同第II相試験 https://news.medxy.ai/vi/glofitamab-safety-efficacy/Medxy AIvi2026-10-11T03:51:07-07:00Hiệu quả và độ an toàn nổi bật của glofitamab phối hợp polatuzumab-R-CHP trong u lympho tế bào B lớn lan tỏa mới chẩn đoán: Nghiên cứu đa trung tâm pha II https://news.medxy.ai/high-efficacy-and-safety-of-glofitamab-plus-polatuzumab-r-chp-in-newly-diagnosed-diffuse-large-b-cell-lymphoma-a-phase-ii-multicenter-study/Medxy AIen2026-10-11T03:50:49-07:00High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study https://news.medxy.ai/zh/ziftomenib-venetoclax-azacitidine-treatment/Medxy AIzh2026-10-11T03:50:03-07:00Ziftomenib联合Venetoclax与Azacitidine治疗复发/难治性NPM1突变急性髓系白血病：疗效与安全性分析 https://news.medxy.ai/ja/npm1-leukemia-therapy/Medxy AIja2026-10-11T03:49:44-07:00再発／難治性NPM1変異急性骨髄性白血病におけるZiftomenibとVenetoclax・Azacitidine併用療法の有効性と安全性 https://news.medxy.ai/vi/ziftomenib-venetoclax-azacitidine/Medxy AIvi2026-10-11T03:49:24-07:00Ziftomenib phối hợp venetoclax và azacitidine: hiệu quả và độ an toàn đầy hứa hẹn trong AML đột biến NPM1 tái phát/kháng trị https://news.medxy.ai/efficacy-and-safety-of-ziftomenib-combined-with-venetoclax-and-azacitidine-in-relapsed-refractory-npm1-mutated-acute-myeloid-leukemia/Medxy AIen2026-10-11T03:49:04-07:00Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia https://news.medxy.ai/zh/icu-pharmacist-workload/Medxy AIzh2026-10-11T03:48:23-07:00优化 ICU 药师工作负荷：对患者死亡率与用药管理的影响 https://news.medxy.ai/ja/83228-2/Medxy AIja2026-10-11T03:48:08-07:00ICU薬剤師の業務量最適化：患者の死亡率および薬剤管理への影響 https://news.medxy.ai/vi/icu-pharmacist-workload-2/Medxy AIvi2026-10-11T03:47:49-07:00Tối ưu hóa khối lượng công việc của dược sĩ ICU: Tác động đến tử vong người bệnh và quản lý thuốc https://news.medxy.ai/optimizing-icu-pharmacist-workload-impact-on-patient-mortality-and-medication-management/Medxy AIen2026-10-11T03:47:32-07:00Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management https://news.medxy.ai/zh/biologics-severe-asthma/Medxy AIzh2026-10-11T03:46:54-07:00生物制剂适用重症哮喘的加重轨迹：来自英国全国数据的启示 https://news.medxy.ai/ja/severe-asthma-exacerbations/Medxy AIja2026-10-11T03:46:36-07:00生物学的製剤適応の重症喘息における増悪経過：英国全国データが示す新知見 https://news.medxy.ai/vi/severe-asthma-biology/Medxy AIvi2026-10-11T03:46:17-07:00Quỹ đạo kịch phát ở hen phế quản nặng đủ điều kiện điều trị sinh học: góc nhìn từ dữ liệu toàn quốc Vương quốc Anh https://news.medxy.ai/trajectory-of-exacerbations-in-biologic-eligible-severe-asthma-insights-from-uk-nationwide-data/Medxy AIen2026-10-11T03:45:59-07:00Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data https://news.medxy.ai/zh/pediatric-pulmonary-hypertension/Medxy AIzh2026-10-11T03:45:16-07:00儿童肺动脉高压加用sotatercept：Pediatric Pulmonary Hypertension Network带来可喜结果 https://news.medxy.ai/ja/sotatercept-pediatric-hypertension/Medxy AIja2026-10-11T03:44:57-07:00小児肺高血圧症における補助療法としての sotatercept：Pediatric Pulmonary Hypertension Network が示した有望な成績 https://news.medxy.ai/vi/sotatercept-pediatric-ph-therapy/Medxy AIvi2026-10-11T03:44:38-07:00Sotatercept như liệu pháp bổ sung trong tăng áp phổi nhi khoa: Kết quả đầy hứa hẹn từ Pediatric Pulmonary Hypertension Network https://news.medxy.ai/sotatercept-as-add-on-therapy-in-pediatric-pulmonary-hypertension-promising-outcomes-from-the-pediatric-pulmonary-hypertension-network/Medxy AIen2026-10-11T03:44:20-07:00Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network https://news.medxy.ai/ja/preterm-lung-health/Medxy AIja2026-10-11T03:43:39-07:00早産後の肺健康：生涯にわたる呼吸器ケアに向けた実践的コンセンサス https://news.medxy.ai/vi/lung-health-preterm/Medxy AIvi2026-10-11T03:43:06-07:00Sức khỏe phổi sau sinh non: Đồng thuận thực hành cho chăm sóc hô hấp suốt đời https://news.medxy.ai/zh/preterm-lung-health-2/Medxy AIzh2026-10-11T03:42:34-07:00早产后肺健康：终身呼吸照护的实用共识 https://news.medxy.ai/lung-health-after-preterm-birth-practical-consensus-for-lifelong-respiratory-care/Medxy AIen2026-10-11T03:42:05-07:00Lung Health after Preterm Birth: Practical Consensus for Lifelong Respiratory Care https://news.medxy.ai/zh/83173-2/Medxy AIzh2026-10-11T03:41:02-07:00肠道菌群与特发性肺纤维化：与疾病严重程度及生存转归的关联 https://news.medxy.ai/ja/gut-microbiota-ipf/Medxy AIja2026-10-11T03:40:45-07:00腸内細菌叢と特発性肺線維症：疾患重症度と生存転帰との関連